Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation

New England Journal of Medicine

Volumn 342, Issue 20, 2000, Pages 1471-1477

  Kress, John P ^a   Pohlman, Anne S ^a   O'Connor, Michael F ^a   Hall, Jesse B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM; PROPOFOL; SEDATIVE AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CRITICAL ILLNESS; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MENTAL HEALTH; PRIORITY JOURNAL; SEDATION;

ADULT; AGED; ANALGESICS, OPIOID; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDAZOLAM; MIDDLE AGED; MORPHINE; PROPOFOL; RESPIRATION, ARTIFICIAL;

EID: 0034682246     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200005183422002     Document Type: Article

References (29)

1. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA 1991; 266:2870-5.
2. Christensen BV, Thunedborg LP. Use of sedatives, analgesics and neuromuscutar blocking agents in Danish ICUs 1996/97: a national survey. Intensive Care Med 1999;25:186-91.
3. Chamorro C, de Latorre FJ, Montero A, et al. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. Crit Care Med 1996;24: 932-9.
4. Carrasco G, Molina R, Costa J, Soler JM, Cabre L. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients: a cost-benefit analysis. Chest 1993;103:557-64.
5. Riker RR, Fraser GL, Cox PM. Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 1994;22:433-40.
6. Bidani A, Tzouanakis AE, Cardenas VJ Jr, Zwischenberger JB. Permissive hypercapnia in acute respiratory failure. JAMA 1994;272:957-62.
7. Feihl F, Perret C. Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994;150:1722-37.
8. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998;26:947-56.
9. Jacobs JR, Reves JG, Glass PSA. Rationale and technique for continuous infusions in anesthesia. Int Anesthesiol Clin 1991;29:23-38.
10. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998;114:541-8.
11. Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ 1974;2:656-9.
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
13. Kress JP, O'Connor MF, Pohlman AS, et al. Sedation of critically ill patients during mechanical ventilation: a comparison of propofol and midazolam. Am J Respir Crit Care Med 1996;153:1012-8
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
16. Wood LDH. The pathophysiology and differential diagnosis of acute respiratory failure. In: Hall JB, Schmidt GA, Wood LDH. Principles of critical care. 2nd ed. New York: McGraw-Hill, 1998:499-508.
17. Shelly MP. Sedation, where are we now? Intensive Care Med 1999;25: 137-9.
18. Halpern NA, Bettes L, Greenstein R. Federal and nationwide intensive care units and Healthcare costs: 1986-1992. Crit Care Med 1994;22:2001-7.
19. Gundlach CA, Faulkner TP, Souney PF. Drug usage patterns in the ICU: profile of a major metropolitan hospital and comparison with other ICUs. Hosp Formul 1991;26:132-6.
20. Cheng EY. The cost of sedating and paralyzing the critically ill patient. Crit Care Clin 1995;11:1005-19.
21. 1999 New York Times almanac. New York: Penguin Reference Books, 1998:316.
22. Swart EL, van Schijndel RJM, van Loenen AC, Thijs LG. Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med 1999;27:1461-5.
23. Sivam SP, Ho IK. GABA in morphine analgesia and tolerance. Life Sci 1985;37:199-208.
24. Ronan KP, Gallagher TJ, George B, Hamby B. Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med 1995;23:286-93.
25. Mirski MA, Muffelman B, Ulatowski JA, Hanley DF. Sedation for the critically ill neurologic patient. Crit Care Med 1995;23:2038-53.
26. Braman SS, Dunn SM, Amico CA, Millman RP. Complications of intrahospital transport in critically ill patients. Ann Intern Med 1987;107: 469-73.
27. Indeck M, Peterson S, Smith J, Brotman S. Risk, cost, and benefit of transporting ICU patients for special studies. J Trauma 1988;28:1020-5.
28. Vassal T, Anh NGD, Gabillet JM, Guidet B, Staikowsky F, Offenstadt G. Prospective evaluation of self-extubations in a medical intensive care unit. Intensive Care Med 1993;19:340-2.
29. Boulain T, Association des Reanimateurs du Centre-Ouest. Unplanned extubations in the adult intensive care unit: a prospective multicenter study. Am J Respir Crit Care Med 1998;157:1131-7.